196 related articles for article (PubMed ID: 2450326)
21. Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
Deguchi H; Deguchi K; Tsukada T; Murashima S; Iwasaki E; Tsuda M; Kobayashi T; Shirakawa S
Intern Med; 1994 Feb; 33(2):100-2. PubMed ID: 7517229
[TBL] [Abstract][Full Text] [Related]
22. Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary.
Norton JA; Kerlan RK
Cancer J; 2003; 9(4):241-3. PubMed ID: 12967132
[No Abstract] [Full Text] [Related]
23. Long-term survival and nearly asymptomatic course of carcinoid tumour with multiple metastases (treated by surgery, chemotherapy, (90)Y-DOTATATE, and LAR octreotide analogue): a case report.
Kałuzny M; Bolanowski M; Sukiennik-Kujawa M; Ponikowski P; Handkiewicz-Junak D; Jarzab B; Jawiarczyk A; Syrycka J
Endokrynol Pol; 2009; 60(5):401-6. PubMed ID: 19885812
[TBL] [Abstract][Full Text] [Related]
24. Embolization of the liver in the management of metastatic carcinoid tumors.
Mårtensson H; Nobin A; Bengmark S; Lunderquist A; Owman T; Sandén G
J Surg Oncol; 1984 Nov; 27(3):152-8. PubMed ID: 6208426
[TBL] [Abstract][Full Text] [Related]
25. Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.
Biesma B; Willemse PH; Mulder NH; Verschueren RC; Kema IP; de Bruijn HW; Postmus PE; Sleijfer DT; de Vries EG
Br J Cancer; 1992 Nov; 66(5):850-5. PubMed ID: 1384643
[TBL] [Abstract][Full Text] [Related]
26. [Pronounced flush symptoms in carcinoid syndrome without liver metastases].
Roth J; Raschka C; Hammar CH
Leber Magen Darm; 1994 Nov; 24(6):259-61. PubMed ID: 7531269
[TBL] [Abstract][Full Text] [Related]
27. Metastatic carcinoid tumors and the malignant carcinoid syndrome.
Kvols LK
Ann N Y Acad Sci; 1994 Sep; 733():464-70. PubMed ID: 7978896
[No Abstract] [Full Text] [Related]
28. Efficient symptomatic control of carcinoid tumors with somatostatin in patients with disease progression under alpha-interferon therapy.
Boehme MW; Schmidt-Gayk H; Bihl H; Eisenhut M; Herfarth CH; Kommere B; Raeth U
Hepatogastroenterology; 1995; 42(6):1053-61. PubMed ID: 8847018
[TBL] [Abstract][Full Text] [Related]
29. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour.
Rönnblom LE; Alm GV; Oberg KE
J Intern Med; 1990 Mar; 227(3):207-10. PubMed ID: 1690258
[TBL] [Abstract][Full Text] [Related]
30. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization.
Hanssen LE; Schrumpf E; Kolbenstvedt AN; Tausjø J; Dolva LO
Scand J Gastroenterol; 1989 Sep; 24(7):787-95. PubMed ID: 2477894
[TBL] [Abstract][Full Text] [Related]
31. Extended experience with recombinant alpha-2b interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report.
Hanssen LE; Schrumpf E; Jacobsen MB; Kolbenstvedt AN; Kolmannskog F; Bergan A; Dolva LO
Acta Oncol; 1991; 30(4):523-7. PubMed ID: 1854510
[TBL] [Abstract][Full Text] [Related]
32. MHC class I and II antigen expression and interferon alpha treatment of human midgut carcinoid tumors.
Makridis C; Juhlin C; Akerström G; Oberg K; Rastad J
World J Surg; 1994; 18(4):481-6; discussion 486-7. PubMed ID: 7725732
[TBL] [Abstract][Full Text] [Related]
33. Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization.
Diaco DS; Hajarizadeh H; Mueller CR; Fletcher WS; Pommier RF; Woltering EA
Am J Surg; 1995 May; 169(5):523-8. PubMed ID: 7747834
[TBL] [Abstract][Full Text] [Related]
34. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
de Herder WW
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.
Funa K; Alm GV; Rönnblom L; Oberg K
Clin Exp Immunol; 1983 Sep; 53(3):716-24. PubMed ID: 6616963
[TBL] [Abstract][Full Text] [Related]
36. Octreotide and interferon alfa: a new combination for the treatment of malignant carcinoid tumours.
Tiensuu Janson EM; Ahlström H; Andersson T; Oberg KE
Eur J Cancer; 1992; 28A(10):1647-50. PubMed ID: 1382492
[TBL] [Abstract][Full Text] [Related]
37. Transcatheter chemoembolization of progressive carcinoid liver metastasis.
Therasse E; Breittmayer F; Roche A; De Baere T; Indushekar S; Ducreux M; Lasser P; Elias D; Rougier P
Radiology; 1993 Nov; 189(2):541-7. PubMed ID: 7692465
[TBL] [Abstract][Full Text] [Related]
38. Transcatheter arterial chemoembolization with DSM for primary hepatic malignant carcinoid.
Hijioka S; Ikari T; Kamei A; Takano K; Asahara S; Fujita N; Shimizu M; Kuraoka K; Fijita R; Kanda H; Kato Y
Hepatogastroenterology; 2007 Mar; 54(74):382-5. PubMed ID: 17523279
[TBL] [Abstract][Full Text] [Related]
39. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.
Winkelbauer FW; Niederle B; Pietschmann F; Thurnher S; Wildling R; Prokesch R; Lammer J
AJR Am J Roentgenol; 1995 Aug; 165(2):323-7. PubMed ID: 7542430
[TBL] [Abstract][Full Text] [Related]
40. Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.
Schöber C; Schmoll E; Schmoll HJ; Poliwoda H; Schuppert F; Stahl M; Bokemeyer C; Wilke H; Weiss J
Eur J Cancer; 1992; 28A(10):1664-6. PubMed ID: 1382494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]